Lexcen, Daniel
24  Ergebnisse:
Personensuche X
?
 
?
5

Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Ne..:

Lexcen, Daniel
https://openresearchlibrary.org/viewer/a5a66e92-4557-42c5-807f-1a86e1ba68b5.  , 2012
 
?
6

Urine Metabolomics in Hemorrhagic Shock: Normalization of U..:

R. Lusczek, Elizabeth ; Nelson, Teresa ; Lexcen, Daniel...
info:eu-repo/semantics/altIdentifier/doi/10.4172/1948-593x.1000041.  , 2011
 
?
 
?
 
?
10

Risk Factors for CIED Infection After Secondary Procedures:

Tarakji, Khaldoun G ; Krahn, Andrew D ; Poole, Jeanne E...
Reproducció del document publicat a: https://doi.org/10.1016/j.jacep.2021.08.009.  , 2021
 
?
11

Use of healthcare claims to validate the Prevention of Arrh..:

Ahmed, Fozia Z ; Blomström-Lundqvist, Carina ; Bloom, Heather...
Ahmed , F Z , Blomström-Lundqvist , C , Bloom , H , Cooper , C , Ellis , C , Goette , A , Greenspon , A J , Love , C J , Johansen , J B , Philippon , F , Tarakji , K G , Holbrook , R , Sherfesee , L , Xia , Y , Seshadri , S , Lexcen , D R & Krahn , A D 2021 , ' Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score ' , Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology , vol. 23 , no. 9 , pp. 1446-1455 . https://doi.org/10.1093/europace/euab028.  , 2021
 
1-15